Drugs / PTP-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01962909 | Nov 2013 → Jan 2016 | pancreatic ductal adenocarcinoma | University of Virginia | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PTP-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01962909 ↗ |
| Modality | Peptide | “50ug of peptide” NCT01962909 ↗ |
| Route | Intravenous | “single IV bolus dose 24 hours prior to surgery” NCT01962909 ↗ |